Serial Number | 90713374 |
Word Mark | IFORMULATE |
Filing Date | Saturday, May 15, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 31, 2022 |
Registration Number | 6743350 |
Registration Date | Tuesday, May 31, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 15, 2022 |
Pseudo Mark | I FORMULATE |
Goods and Services | Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs), all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pH, ionic strength, buffer and stability concentrations, all the foregoing using Design of Experiments Approach in a multivariate fashion |
Goods and Services | Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 13, 2021 |
Primary Code | 001 |
First Use Anywhere Date | Monday, June 28, 2010 |
First Use In Commerce Date | Monday, June 28, 2010 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 13, 2021 |
Primary Code | 042 |
First Use Anywhere Date | Sunday, March 28, 2010 |
First Use In Commerce Date | Monday, June 28, 2010 |
Party Name | HTD Biosystems, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Pleasanton, CA 94566 |
Party Name | HTD Biosystems, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Pleasanton, CA 94566 |
Party Name | HTD Biosystems, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Pleasanton, CA 94566 |
Event Date | Event Description |
Thursday, April 20, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, April 20, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Thursday, April 20, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, April 20, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, May 31, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, May 31, 2022 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, March 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, March 15, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, February 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, February 10, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Tuesday, February 8, 2022 | ASSIGNED TO LIE |
Friday, February 4, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, January 31, 2022 | EXAMINER'S AMENDMENT ENTERED |
Monday, January 31, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, January 31, 2022 | EXAMINERS AMENDMENT E-MAILED |
Monday, January 31, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, January 25, 2022 | ASSIGNED TO EXAMINER |
Friday, August 13, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, May 19, 2021 | NEW APPLICATION ENTERED |